Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
Tissue plasminogen activator (t-PA) causes fibrinogen proteolysis when alpha 2-antiplasmin levels fall, and this may contribute to t-PA-induced hemorrhage. Because clot-bound plasmin is protected from alpha 2-antiplasmin inhibition, we tested the possibility that alpha 2-antiplasmin supplementation...
Сохранить в:
| Опубликовано в:: | J Clin Invest |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
1993
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC288105/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7682569/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116335 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
